Cedric Richlitzki
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Exploring Thoracic Radiotherapy in Metastatic NSCLC: A Retrospective Review in the Era of Immunotherapy and Targeted Therapies.
Journal: Clinical lung cancer
Published: November 24, 2025
Real-world insights into moderately hypofractionated thoracic radiotherapy in elderly and multimorbid patients with stage II/III NSCLC: a retrospective study.
Journal: Acta oncologica (Stockholm, Sweden)
Published: March 28, 2025
Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy.
Journal: Seminars in nuclear medicine
Published: February 26, 2025
Empiric stereotactic body radiotherapy for presumed early-stage lung cancer : Pulmonary function changes, treatment-related toxicity and survival outcome.
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: January 08, 2025
Assessing ChatGPT's Educational Potential in Lung Cancer Radiotherapy From Clinician and Patient Perspectives: Content Quality and Readability Analysis.
Journal: JMIR cancer
Published: December 08, 2024
C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy.
Journal: Scientific reports
Published: March 15, 2024
Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment-Comparison with Stage III Disease.
Journal: Cancers
Published: February 05, 2024
Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer: focus on treatment selection and prognostic factors.
Journal: Immunotherapy
Published: July 13, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026